For a patient who self‑treated chronic pain with high‑dose thiamine (100 mg three times daily for 6 days, now 100 mg daily) and is also taking vitamin K2 (MK‑7), vitamin D3, magnesium glycinate 200 mg, vitamin B2 2 mg, vitamins B3 and B6, and a Kate Farms peptide drink, what office laboratory tests and at‑home monitoring protocol should be implemented?

Office Testing and At-Home Protocol for Patient on High-Dose Thiamine

Continue the current maintenance dose of 100 mg thiamine daily and obtain RBC or whole blood thiamine diphosphate (ThDP) testing to confirm the suspected deficiency and guide ongoing management. 1

Immediate Office Laboratory Testing

Measure RBC or whole blood thiamine diphosphate (ThDP) as the primary diagnostic test. 1 This is the gold standard biomarker (Grade A recommendation) and is not affected by inflammation, making it reliable for confirming thiamine deficiency. 1 If ThDP testing is unavailable, consider red cell transketolase activity with thiamine activation coefficient as an alternative. 1

Additional Laboratory Work to Consider:

• Complete metabolic panel - to assess for metabolic lactic acidosis, which can indicate thiamine deficiency 1
• Lactate and pyruvate levels - supportive biomarkers of thiamine deficiency 1
• Vitamin D level - since patient is taking D3 but dose is unknown
• Magnesium level - to ensure adequate supplementation (patient taking 200 mg glycinate)
• Vitamin B6 level - to monitor for potential toxicity with chronic supplementation 2
• Complete blood count - rare but documented cases of thiamine-induced thrombocytopenia exist 3

Current Dosing Assessment

The patient's self-initiated regimen of 100 mg three times daily for 6 days followed by 100 mg daily actually aligns well with guideline recommendations. 1 According to ESPEN guidelines, the maintenance dose for proven deficiency is 50-100 mg/day orally, which is exactly what the patient is now taking. 1

The dramatic 6-day response strongly suggests thiamine deficiency was the underlying cause of the 8-month pain syndrome. This rapid improvement is characteristic of thiamine-responsive disorders. 4

Recommended Ongoing Protocol

Thiamine Management:

• Continue 100 mg daily orally as maintenance therapy for at least 6 weeks 1
• After 6 weeks, if symptoms remain resolved and ThDP levels normalize, consider reducing to 3-5 mg daily for long-term maintenance 1
• Do not discontinue abruptly - thiamine reserves deplete within 20 days of inadequate intake 1

Safety Monitoring:

Thiamine has no established upper limit and is remarkably safe. 1 The FDA notes that doses of 100-500 mg are administered without toxic effects, though doses exceeding 30 mg three times daily result in urinary excretion of excess. 5 The only documented risks are:

• Rare anaphylaxis with IV administration (not relevant for oral use) 5
• Doses >400 mg may cause nausea, anorexia, mild ataxia 1
• Extremely rare thrombocytopenia (one case report with IV use) 3

At-Home Monitoring Protocol:

Patient should monitor and report:

• Pain levels - document any recurrence using a 0-10 scale daily for first month
• Neurological symptoms - numbness, tingling, weakness, confusion, memory changes
• Cardiovascular symptoms - shortness of breath, leg swelling, rapid heartbeat (beriberi can affect the heart) 1
• Gastrointestinal tolerance - nausea or appetite changes
• Energy levels - fatigue is a key indicator of thiamine status 6

Investigation of Underlying Cause

Critical: Identify why this patient developed thiamine deficiency. 1 Common risk factors include:

• Chronic diuretic use
• Malabsorption (GI surgery, inflammatory bowel disease, chronic diarrhea)
• Alcohol consumption
• Poor dietary intake/malnutrition
• Diabetes
• Bariatric surgery history
• Medications that interfere with thiamine (metformin, furosemide, metronidazole) 7

Obtain detailed history regarding:

• Medication list (especially diuretics, metformin, proton pump inhibitors)
• Alcohol intake
• Dietary patterns
• GI symptoms or surgeries
• Weight loss
• Chronic illnesses

Multi-Vitamin Supplementation Review

The patient's current regimen includes B-complex vitamins, which is appropriate since B vitamins work synergistically in metabolic pathways. 8 However:

• Vitamin B6 requires monitoring - chronic high-dose supplementation can cause peripheral neuropathy, though this typically occurs with very high doses (>200 mg/day) over prolonged periods 2
• Vitamin D3 and K2 MK-7 - obtain baseline vitamin D level to guide appropriate dosing
• Magnesium 200 mg - reasonable dose; magnesium is a cofactor in thiamine-dependent reactions

Follow-Up Timeline

• 2-4 weeks: Review laboratory results, assess symptom stability
• 6 weeks: Consider transitioning to lower maintenance dose if ThDP normalized and symptoms resolved
• 3 months: Repeat ThDP level to confirm adequacy of maintenance therapy
• Ongoing: Annual monitoring if risk factors persist

Key Clinical Pitfalls to Avoid

1. Do not assume resolution means no underlying pathology - the deficiency developed for a reason that must be identified
2. Do not discontinue thiamine prematurely - reserves deplete rapidly 1
3. Do not ignore the dramatic response - this confirms the diagnosis and validates continued treatment
4. Do not overlook medication-induced deficiency - many common drugs interfere with thiamine 7
5. Do not delay testing - while treatment should continue, confirmation guides long-term management

The patient's self-treatment was remarkably appropriate and the response validates thiamine deficiency as the cause of the chronic pain syndrome. The priority now is confirming the diagnosis biochemically and identifying the underlying cause to prevent recurrence.